非糖尿病和糖尿病人冠状动脉内皮细胞模拟心梗缺血/再灌注后蛋白激酶C-β的抑制和生存信号传导

IF 3.8 2区 医学 Q1 SURGERY
Ju-Woo Nho, Debolina Banerjee, Dwight D Harris, Christopher Stone, Hang Xing, Meghamsh Kanuparthy, Janelle Li, Frank W Sellke, Jun Feng
{"title":"非糖尿病和糖尿病人冠状动脉内皮细胞模拟心梗缺血/再灌注后蛋白激酶C-β的抑制和生存信号传导","authors":"Ju-Woo Nho, Debolina Banerjee, Dwight D Harris, Christopher Stone, Hang Xing, Meghamsh Kanuparthy, Janelle Li, Frank W Sellke, Jun Feng","doi":"10.1097/XCS.0000000000001248","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardioplegic-ischemia/reperfusion (I/R) injury poses substantial challenges during postoperative recovery, with diabetic patients particularly susceptible to adverse events. Using a model entailing the subjection of human coronary artery endothelial cells (HCAECs) to simulated cardioplegic I/R, we investigated the potential of protein kinase C β (PKC-β) inhibition to augment cellular survival in this context.</p><p><strong>Study design: </strong>HCAECs were isolated from harvested coronary arteries of diabetic (D) and nondiabetic (C) patients (N = 4 per group). HCAECs were either cultured under normoxic conditions without drug (D and C), subjected to hypoxia and reoxygenation alone (DH and CH), or subjected to hypoxia and reoxygenation and the PKC-β inhibitor LY333531 (DHT and CHT). Molecular signaling was assessed using immunoblotting.</p><p><strong>Results: </strong>Simulated I/R decreased anti-apoptotic phosphorylated protein kinase b (p-Akt, p = 0.04) and p-Akt:Akt ratio (p = 0.004) in CH vs C, with PKC-β inhibition restoring expression in CHT (p ≤ 0.04). Treatment also increased the p-Akt:Akt ratio in DHT vs D (p = 0.03). Anti-apoptotic inducible nitric oxide synthase increased in CHT vs CH (p = 0.003), and the pro-apoptotic phosphorylated class O forkhead box transcription factor (p-FOXO): FOXO ratio decreased in CHT vs CH (p = 0.001). I/R elevated Bcl-2-associated agonist of cell death (BAD) in CH vs C (p = 0.01), but PKC-β inhibition increased anti-apoptotic p-BAD (p = 0.001) and p-BAD:BAD ratio (p = 0.03) in CHT. I/R also increased cleaved PARP (p < 0.001) and cleaved caspase 3 (p < 0.001) in DH vs D, both of which were reversed by treatment (p < 0.001 for DHT vs DH).</p><p><strong>Conclusions: </strong>PKC-β inhibitor treatment increased pro-survival signaling and decreased pro-apoptotic signaling in nondiabetic and diabetic HCAECs subjected to simulated I/R, with mechanistic differences observed between these cohorts.</p>","PeriodicalId":17140,"journal":{"name":"Journal of the American College of Surgeons","volume":" ","pages":"118-135"},"PeriodicalIF":3.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12147101/pdf/","citationCount":"0","resultStr":"{\"title\":\"Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic-Ischemia/Reperfusion in Nondiabetic and Diabetic Human Coronary Arterial Endothelial Cells.\",\"authors\":\"Ju-Woo Nho, Debolina Banerjee, Dwight D Harris, Christopher Stone, Hang Xing, Meghamsh Kanuparthy, Janelle Li, Frank W Sellke, Jun Feng\",\"doi\":\"10.1097/XCS.0000000000001248\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cardioplegic-ischemia/reperfusion (I/R) injury poses substantial challenges during postoperative recovery, with diabetic patients particularly susceptible to adverse events. Using a model entailing the subjection of human coronary artery endothelial cells (HCAECs) to simulated cardioplegic I/R, we investigated the potential of protein kinase C β (PKC-β) inhibition to augment cellular survival in this context.</p><p><strong>Study design: </strong>HCAECs were isolated from harvested coronary arteries of diabetic (D) and nondiabetic (C) patients (N = 4 per group). HCAECs were either cultured under normoxic conditions without drug (D and C), subjected to hypoxia and reoxygenation alone (DH and CH), or subjected to hypoxia and reoxygenation and the PKC-β inhibitor LY333531 (DHT and CHT). Molecular signaling was assessed using immunoblotting.</p><p><strong>Results: </strong>Simulated I/R decreased anti-apoptotic phosphorylated protein kinase b (p-Akt, p = 0.04) and p-Akt:Akt ratio (p = 0.004) in CH vs C, with PKC-β inhibition restoring expression in CHT (p ≤ 0.04). Treatment also increased the p-Akt:Akt ratio in DHT vs D (p = 0.03). Anti-apoptotic inducible nitric oxide synthase increased in CHT vs CH (p = 0.003), and the pro-apoptotic phosphorylated class O forkhead box transcription factor (p-FOXO): FOXO ratio decreased in CHT vs CH (p = 0.001). I/R elevated Bcl-2-associated agonist of cell death (BAD) in CH vs C (p = 0.01), but PKC-β inhibition increased anti-apoptotic p-BAD (p = 0.001) and p-BAD:BAD ratio (p = 0.03) in CHT. I/R also increased cleaved PARP (p < 0.001) and cleaved caspase 3 (p < 0.001) in DH vs D, both of which were reversed by treatment (p < 0.001 for DHT vs DH).</p><p><strong>Conclusions: </strong>PKC-β inhibitor treatment increased pro-survival signaling and decreased pro-apoptotic signaling in nondiabetic and diabetic HCAECs subjected to simulated I/R, with mechanistic differences observed between these cohorts.</p>\",\"PeriodicalId\":17140,\"journal\":{\"name\":\"Journal of the American College of Surgeons\",\"volume\":\" \",\"pages\":\"118-135\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12147101/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American College of Surgeons\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/XCS.0000000000001248\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Surgeons","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/XCS.0000000000001248","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

背景:心脏麻痹性缺血/再灌注(I/R)损伤在术后恢复过程中提出了重大挑战,糖尿病患者尤其容易发生不良事件。通过将人冠状动脉内皮细胞(HCAECs)置于模拟心脏麻痹I/R的模型,我们研究了蛋白激酶c β (PKC-β)抑制在这种情况下增加细胞存活的潜力。研究设计:从糖尿病(D)和非糖尿病(C)患者的冠状动脉中分离hcaec(每组N = 4)。hcaec分别在无药物(D和C)的常氧条件下培养,单独缺氧/再氧化(DH和CH),或缺氧/再氧化和PKC-β抑制剂LY333531 (DHT和CHT)。采用免疫印迹法评估分子信号。结果:与C相比,模拟I/R降低了CH中抗凋亡磷酸化蛋白激酶b (p-Akt, p = 0.04)和p-Akt:Akt比值(p = 0.004), PKC-β抑制恢复了CHT中的表达(p≤0.04)。DHT与D的p-Akt:Akt比值也升高(p = 0.03)。抗凋亡诱导型一氧化氮合酶在CHT组高于CH组(p = 0.003),促凋亡磷酸化FOXO:FOXO比值低于CH组(p = 0.001)。与C相比,I/R升高了CH中bcl -2相关的细胞死亡激动剂(BAD) (p = 0.01),但PKC-β抑制增加了CHT中抗凋亡的p-BAD (p = 0.001)和p-BAD:BAD比值(p = 0.03)。I/R在DH和D组中也增加了裂解的PARP (p < 0.001)和裂解的caspase 3 (p < 0.001),治疗后两者均逆转(DHT和DH组p < 0.001)。结论:PKC-β抑制剂治疗在模拟I/R的非糖尿病和糖尿病hcaec中增加促生存信号和降低促凋亡信号,在这些队列中观察到机制差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic-Ischemia/Reperfusion in Nondiabetic and Diabetic Human Coronary Arterial Endothelial Cells.

Background: Cardioplegic-ischemia/reperfusion (I/R) injury poses substantial challenges during postoperative recovery, with diabetic patients particularly susceptible to adverse events. Using a model entailing the subjection of human coronary artery endothelial cells (HCAECs) to simulated cardioplegic I/R, we investigated the potential of protein kinase C β (PKC-β) inhibition to augment cellular survival in this context.

Study design: HCAECs were isolated from harvested coronary arteries of diabetic (D) and nondiabetic (C) patients (N = 4 per group). HCAECs were either cultured under normoxic conditions without drug (D and C), subjected to hypoxia and reoxygenation alone (DH and CH), or subjected to hypoxia and reoxygenation and the PKC-β inhibitor LY333531 (DHT and CHT). Molecular signaling was assessed using immunoblotting.

Results: Simulated I/R decreased anti-apoptotic phosphorylated protein kinase b (p-Akt, p = 0.04) and p-Akt:Akt ratio (p = 0.004) in CH vs C, with PKC-β inhibition restoring expression in CHT (p ≤ 0.04). Treatment also increased the p-Akt:Akt ratio in DHT vs D (p = 0.03). Anti-apoptotic inducible nitric oxide synthase increased in CHT vs CH (p = 0.003), and the pro-apoptotic phosphorylated class O forkhead box transcription factor (p-FOXO): FOXO ratio decreased in CHT vs CH (p = 0.001). I/R elevated Bcl-2-associated agonist of cell death (BAD) in CH vs C (p = 0.01), but PKC-β inhibition increased anti-apoptotic p-BAD (p = 0.001) and p-BAD:BAD ratio (p = 0.03) in CHT. I/R also increased cleaved PARP (p < 0.001) and cleaved caspase 3 (p < 0.001) in DH vs D, both of which were reversed by treatment (p < 0.001 for DHT vs DH).

Conclusions: PKC-β inhibitor treatment increased pro-survival signaling and decreased pro-apoptotic signaling in nondiabetic and diabetic HCAECs subjected to simulated I/R, with mechanistic differences observed between these cohorts.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.90
自引率
5.80%
发文量
1515
审稿时长
3-6 weeks
期刊介绍: The Journal of the American College of Surgeons (JACS) is a monthly journal publishing peer-reviewed original contributions on all aspects of surgery. These contributions include, but are not limited to, original clinical studies, review articles, and experimental investigations with clear clinical relevance. In general, case reports are not considered for publication. As the official scientific journal of the American College of Surgeons, JACS has the goal of providing its readership the highest quality rapid retrieval of information relevant to surgeons.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信